ý
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
|
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
|
Delaware
|
59-3134518
|
|
(State
or other jurisdiction of
|
(I.R.S.Employer
|
|
incorporation
or organization)
|
Identification
Number)
|
PART
I – FINANCIAL INFORMATION
|
Page
|
|
Item
1
|
Financial
Statements
|
4
|
Item
2
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
19
|
Item
3
|
Quantitative
and Qualitative Disclosures about Market Risk
|
27
|
Item
4
|
Controls
and Procedures
|
27
|
PART
II – OTHER INFORMATION
|
||
Item
1
|
Legal
Proceedings
|
28
|
Item
1A
|
Risk
Factors
|
28
|
Item
2
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
28
|
Item
3
|
Defaults
Upon Senior Securities
|
28
|
Item
4
|
Submission
of Matters to a Vote of Security Holders
|
28
|
Item
5
|
Other
Information
|
28
|
Item
6
|
Exhibits
|
29
|
Signatures
|
30
|
September 30,
|
December 31,
|
||||||
2008
|
2007
|
||||||
ASSETS
|
(Unaudited)
|
|
|
(Audited)
|
|
||
Cash
and cash equivalents
|
$
|
761
|
$
|
1,770
|
|||
Trade
receivables
|
1,141
|
2,464
|
|||||
Inventories,
net
|
1,023
|
1,400
|
|||||
Prepaid
expenses and other current assets
|
105
|
32
|
|||||
Total
current assets
|
3,030
|
5,666
|
|||||
Fixed
assets, net
|
97
|
127
|
|||||
Total
assets
|
$
|
3,127
|
$
|
5,793
|
|||
LIABILITIES
AND STOCKHOLDERS’ EQUITY (DEFICIT)
|
|||||||
Current
liabilities:
|
|||||||
Notes
payable
|
$
|
-
|
$
|
989
|
|||
Trade
payables to related parties
|
560
|
578
|
|||||
Trade
payables and other current liabilities
|
278
|
658
|
|||||
Deferred
revenue and customer deposits
|
234
|
-
|
|||||
Fair
value of warrant liability
|
432
|
399
|
|||||
Accrued
dividends on Series A 5% cumulative convertible preferred
stock
|
-
|
178
|
|||||
Total
current liabilities
|
1,504
|
2,802
|
|||||
Long-term
bank line of credit
|
-
|
2,021
|
|||||
Liability
under derivative contracts
|
536
|
255
|
|||||
Total
liabilities
|
2,040
|
5,078
|
|||||
Commitments
and contingencies (Note 10)
|
|||||||
Convertible
preferred stock, $.001 par value, 2,000 authorized:
|
|||||||
Series
A 5% cumulative convertible preferred stock, 0 and 11.5 shares
issued
and outstanding at September 30, 2008 and December 31, 2007, respectively;
liquidation value of $0 and $1,150 at September 30, 2008 and
December 31, 2007, respectively
|
-
|
1,074
|
|||||
Series
B convertible preferred stock, 1.5 shares issued and outstanding
at September 30, 2008 and December 31, 2007; liquidation value
of $150 at September 30, 2008 and December 31, 2007
|
107
|
70
|
|||||
Stockholders’
equity (deficit):
|
|||||||
Common
stock $.001par value, 50,000 authorized, 18,444 shares
issued and
outstanding at September 30, 2008 and 15,904 shares issued and
15,404 outstanding at December 31, 2007 (500 shares held in
escrow)
|
18
|
15
|
|||||
Additional
paid-in capital
|
32,211
|
30,174
|
|||||
Accumulated
deficit
|
(31,249
|
)
|
(30,618
|
)
|
|||
Total
stockholders’ equity (deficit)
|
980
|
(429
|
)
|
||||
Total
liabilities and stockholders’ equity (deficit)
|
$
|
3,127
|
$
|
5,793
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
Net
sales
|
$
|
3,019
|
$
|
3,296
|
$
|
8,560
|
$
|
11,119
|
|||||
Cost
of sales
|
1,986
|
1,975
|
5,811
|
6,609
|
|||||||||
Gross
profit
|
1,033
|
1,321
|
2,749
|
4,510
|
|||||||||
Operating
expenses:
|
|||||||||||||
Selling,
general and administrative
|
836
|
920
|
2,308
|
3,210
|
|||||||||
Research
and development
|
166
|
526
|
539
|
2,052
|
|||||||||
Total
operating expenses
|
1,002
|
1,446
|
2,847
|
5,262
|
|||||||||
Operating
income (loss)
|
31
|
(125
|
)
|
(98
|
)
|
(752
|
)
|
||||||
Non-operating
income (expense), net:
|
|||||||||||||
Change
in fair value of derivative instruments and warrant
liability
|
(425
|
)
|
(464
|
)
|
(314
|
)
|
(501
|
)
|
|||||
Gain
on sale of assets
|
-
|
-
|
550
|
-
|
|||||||||
Interest
expense and other
|
(157
|
)
|
13
|
(409
|
)
|
33
|
|||||||
Total
non-operating income (expense), net
|
(582
|
)
|
(451
|
)
|
(173
|
)
|
(468
|
)
|
|||||
Net
loss before income taxes
|
(551
|
)
|
(576
|
)
|
(271
|
)
|
(1,220
|
)
|
|||||
Income
tax expense
|
-
|
2
|
2
|
4
|
|||||||||
Net
loss
|
(551
|
)
|
(578
|
)
|
(273
|
)
|
(1,224
|
)
|
|||||
Dividend
on Series A and accretion of Series A and Series B
preferred stock redemption value
|
(13
|
)
|
(237
|
)
|
(127
|
)
|
(721
|
)
|
|||||
Deemed
dividend on Series A preferred stock maturity and Conversion
|
-
|
-
|
(231
|
)
|
-
|
||||||||
Net
loss available to common stockholders
|
$
|
(564
|
)
|
$
|
(815
|
)
|
$
|
(631
|
)
|
$
|
(1,945
|
)
|
|
Loss
per common share - basic and diluted
|
$
|
(0.03
|
)
|
$
|
(0.04
|
)
|
$
|
(0.04
|
)
|
$
|
(0.09
|
)
|
|
Weighted
average common shares outstanding – basic and
diluted
|
18,444
|
21,717
|
17,784
|
22,445
|
Nine Months Ended
September 30,
|
|||||||
|
2008
|
2007
|
|||||
Operating activities
|
|||||||
Net
loss available to common stockholders
|
$
|
(631
|
)
|
$
|
(1,945
|
)
|
|
Adjustments
to reconcile net loss available to common stockholders to net
cash provided by operating activities:
|
|||||||
Depreciation
expense
|
37
|
32
|
|||||
Stock-based
compensation cost – options
|
391
|
1,272
|
|||||
Fair
value of warrants issued for services rendered
|
69
|
14
|
|||||
Interest
expense attributable to amortization of debt issuance
costs
|
311
|
2
|
|||||
Change
in fair value of derivative instruments
|
281
|
501
|
|||||
Change
in fair value of warrant liability
|
33
|
-
|
|||||
Accretion
of Series A and Series B preferred stock redemption value
|
113
|
657
|
|||||
Deemed
dividend on Series A preferred stock
|
231
|
-
|
|||||
Changes
in operating assets and liabilities:
|
|||||||
Trade
receivables
|
1,323
|
(118
|
)
|
||||
Inventories
|
377
|
286
|
|||||
Prepaid
expenses and other current assets
|
(73
|
)
|
(13
|
)
|
|||
Accrued
dividends on Series A 5% cumulative convertible stock
|
13
|
64
|
|||||
Trade
payables to related parties
|
(18
|
)
|
(350
|
)
|
|||
Deferred
revenue and customer deposits
|
234
|
-
|
|||||
Trade
payables and other current liabilities
|
(380
|
)
|
(18
|
)
|
|||
Cash
provided by operating activities
|
2,311
|
384
|
|||||
Investing
activities
|
|||||||
Capital
expenditures
|
(7
|
)
|
(67
|
)
|
|||
Cash
used by investing activities
|
(7
|
)
|
(67
|
)
|
|||
Financing
activities
|
|||||||
Net (payments)
advances on bank line of credit
|
(2,021
|
)
|
487
|
||||
Payments
on notes payable
|
(1,300
|
)
|
-
|
||||
Proceeds
from exercise of employee stock options
|
8
|
-
|
|||||
Cash
(used) provided by financing activities
|
(3,313
|
)
|
487
|
||||
Net
(decrease) increase in cash and cash equivalents
|
(1,009
|
)
|
804
|
||||
Cash
and cash equivalents at beginning of period
|
1,770
|
1,333
|
|||||
Cash
and cash equivalents at end of period
|
$
|
761
|
$
|
2,137
|
|||
Non-cash
investing and financing activities:
|
|||||||
Restricted
common stock acquired from related party
|
$
|
-
|
$
|
2
|
|||
Conversion
of convertible preferred stock to common stock
|
$
|
1,339
|
$
|
525
|
|||
Issuance
of preferred stock warrants in connection with debt
financing
|
$
|
-
|
$
|
399
|
|||
Purchase
of restricted common stock for retirement
|
$
|
-
|
$
|
2,000
|
Three months Ended
September 30,
|
Nine months Ended
September 30,
|
||||||||||||
2008
|
2007
|
|
2008
|
|
2007
|
|
|||||||
Customer A
|
28
|
%
|
26
|
%
|
30
|
%
|
28
|
%
|
|||||
Customer
B
|
20
|
19
|
18
|
15
|
|||||||||
Customer
C
|
19
|
*
|
14
|
14
|
|||||||||
Customer
D
|
11
|
23
|
*
|
13
|
|||||||||
Customer
E
|
*
|
11
|
*
|
*
|
Three months Ended
September 30,
|
Nine months Ended
September 30,
|
||||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
Selling, general
and administrative
|
$
|
147
|
$
|
86
|
$
|
312
|
$
|
816
|
|||||
Research
and development
|
30
|
106
|
79
|
456
|
|||||||||
Total
|
$
|
177
|
$
|
192
|
$
|
391
|
$
|
1,272
|
Weighted
average estimated values per share
|
$
|
0.24
|
||
Expected
option life in years
|
2.0
|
|||
Weighted
average expected volatility
|
175
|
%
|
||
Expected
dividend yield
|
0
|
%
|
||
Weighted
average risk free interest rate
|
2.9
|
%
|
Options
|
Weighted
Average
Exercise
Price
|
||||||
Outstanding at December 31,
2007
|
6,847,550
|
$
|
0.18
|
||||
Granted
|
5,105,000
|
0.30
|
|||||
Exercised
|
(1,446,000
|
)
|
(0.01
|
)
|
|||
Cancelled
|
(1,069,385
|
)
|
(0.77
|
)
|
|||
Outstanding
at September 30, 2008
|
9,437,165
|
$
|
0.32
|
Options Outstanding
|
Options Exercisable
|
|||||||||||||||
Range of
Exercise
Prices
|
Number
Outstanding
|
Weighted
Average
Remaining
Contractual
Life (Years)
|
Weighted
Average
Exercise
Price
|
Number
Exercisable
|
Weighted
Average
Exercise
Price
|
|||||||||||
$0.01
|
2,241,165
|
3.57
|
$
|
0.01
|
2,241,165
|
$
|
0.01
|
|||||||||
$0.30
|
5,105,000
|
9.79
|
$
|
0.30
|
-
|
-
|
||||||||||
$0.60
- $0.70
|
2,091,000
|
8.32
|
$
|
0.69
|
1,304,000
|
$
|
0.70
|
September 30, 2008
|
December 31, 2007
|
||||||||||||||||||
Host Contract
|
Expiration/
Maturity Date
|
Price
$
|
Shares
|
Fair
Value
|
Shares
|
Fair
Value
|
|||||||||||||
Warrants issued with Series A Stock
|
March 15, 2010
|
1.00
|
186.5
|
$
|
75
|
186.5
|
$
|
160
|
|||||||||||
Warrants issued with
Series A Stock
|
March
15, 2010
|
2.00
|
932.5
|
296
|
932.5
|
32
|
|||||||||||||
Warrants
issued with Series B Stock
|
August
7, 2009
|
1.50
|
675.0
|
127
|
675.0
|
41
|
|||||||||||||
Series
A Stock
|
March
15, 2008
|
1.00
|
-
|
-
|
1,150.0
|
-
|
|||||||||||||
Series
B Stock
|
August
7, 2009
|
1.00
|
150.0
|
38
|
150.0
|
22
|
|||||||||||||
Total
|
$
|
536
|
$
|
255
|
September
30, 2008
|
December
31, 2007
|
||||||
Remaining contractual term, Series A Stock
Warrants (years)
|
1.5
|
2.2
|
|||||
Remaining
contractual term, Series B Stock Warrants (years)
|
0.9
|
1.6
|
|||||
Remaining
contractual term, Series A Stock (years)
|
-
|
0.2
|
|||||
Remaining
contractual term, Series B Stock (years)
|
0.9
|
1.6
|
|||||
Average
expected volatility
|
149.0
|
%
|
49.0
|
%
|
|||
Expected
dividend yield
|
-
|
-
|
|||||
Risk
free interest rate
|
1.8
|
%
|
4.0
|
%
|
Year Ending
September 30,
|
Future
Minimum
Lease
Payments
|
|||
2009
|
$
|
242
|
||
2010
|
161
|
|||
2011
|
1
|
|||
Total
|
$
|
404
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
U.S.
|
$
|
2,775
|
$
|
3,103
|
$
|
7,845
|
$
|
10,642
|
|||||
Asia
|
57
|
7
|
101
|
7
|
|||||||||
Europe
and other
|
187
|
186
|
614
|
470
|
|||||||||
$
|
3,019
|
$
|
3,296
|
$
|
8,560
|
$
|
11,119
|
September
30, 2008
|
December
31, 2007
|
||||||
U.S.
|
$
|
3,013
|
$
|
5,574
|
|||
Asia
|
81
|
110
|
|||||
Europe
|
33
|
109
|
|||||
$
|
3,127
|
$
|
5,793
|
·
|
Overview.
This section provides a general description of the Company's business,
as
well as recent developments that we believe are important in understanding
the results of operations and to anticipate future trends in those
operations.
|
·
|
Critical
accounting policies.
This section provides an analysis of the significant estimates and
judgments that affect the reported amounts of assets, liabilities,
revenues and expenses, and related disclosure of contingent assets
and
liabilities.
|
·
|
Results
of operations.
This section provides an analysis of our results of operations for
the
three and nine months ended September 30, 2008 compared to the three
and
nine months ended September 30, 2007. A brief description of certain
aspects, transactions and events is provided, including related-party
transactions that impact the comparability of the results being
analyzed.
|
·
|
Liquidity
and capital resources.
This section provides an analysis of our financial condition and
cash
flows as of and for the nine months ended September 30, 2008 as compared
to the nine months ended September 30,
2007.
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
||||||||||||||||||||||||
2008
|
2007
|
$
|
|
%
|
2008
|
2007
|
$
|
%
|
|||||||||||||||||
Net
sales
|
$
|
3,019
|
$
|
3,296
|
$
|
(277
|
)
|
(8
|
)%
|
$
|
8,560
|
$
|
11,119
|
$
|
(2,559
|
)
|
(23
|
)%
|
|||||||
Cost
of sales
|
1,986
|
1,975
|
11
|
1
|
5,811
|
6,609
|
(798
|
)
|
(12
|
)
|
|||||||||||||||
As
a percentage of sales
|
66
|
%
|
60
|
%
|
68
|
%
|
59
|
%
|
|||||||||||||||||
Selling,
general and administrative expense
|
836
|
920
|
(84
|
)
|
(9
|
)
|
2,308
|
3,210
|
(902
|
)
|
(28
|
)
|
|||||||||||||
Research
and development expense
|
166
|
526
|
(360
|
)
|
(68
|
)
|
539
|
2,052
|
(1,513
|
)
|
(74
|
)
|
|||||||||||||
Total
non-operating income (expense), net
|
(582
|
)
|
(451
|
)
|
NM
|
NM
|
(173
|
)
|
(468
|
)
|
NM
|
NM
|
|||||||||||||
Dividend
and deemed dividend on 5%
convertible preferred stock and accretion
of preferred stock redemption
value
|
(13
|
)
|
(237
|
)
|
NM
|
NM
|
(358
|
)
|
(721
|
)
|
NM
|
NM
|
|||||||||||||
NM
= Not Meaningful
|
·
|
The
negotiated price reduction of our finished
product;
|
·
|
Our
phase out of certain third-party software as we move toward less
costly
third-party software; and
|
·
|
Our
continuing efforts toward reducing the cost of our
products.
|
Nine Months Ended
September 30,
|
|||||||
|
2008
|
2007
|
|||||
Net cash provided by operating
activities
|
$
|
2,311
|
$
|
384
|
|||
Net
cash used by investing activities
|
(7
|
)
|
(67
|
)
|
|||
Net
cash (used) provided by financing activities
|
(3,313
|
)
|
487
|
||||
Net
increase (decrease) in cash and cash equivalents
|
$
|
(1,009
|
)
|
$
|
804
|
Less Than
|
One – Three
|
Three – Five
|
|||||||||||
Total
|
One Year
|
Years
|
Years
|
||||||||||
Bank
line of credit (1)
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
|||||
Warrant
repurchase liability(2)
|
350
|
350
|
-
|
-
|
|||||||||
Series
B Stock principal(3)
|
150
|
-
|
150
|
-
|
|||||||||
Operating
lease obligations
|
404
|
242
|
162
|
-
|
|||||||||
Consulting
agreement
|
15
|
15
|
-
|
-
|
|||||||||
Total
contractual cash obligations
|
$
|
919
|
$
|
607
|
$
|
312
|
$
|
-
|
Number of Shares
|
|||||||||
Voted For
|
|
Withheld
|
|
||||||
(1)
|
To elect a board of directors
to hold office until the next annual stockholders’ meeting or until their
respective successors have been elected or appointed:
|
||||||||
Edward
Straw
|
11,757,523
|
100,000
|
|||||||
David
Clark
|
11,757,523
|
100,000
|
|||||||
William
Hawkins
|
11,757,523
|
100,000
|
|||||||
Frank
Musso
|
11,757,523
|
100,000
|
|||||||
Darwin
Hu
|
11,857,523
|
-
|
Number of Shares
|
||||||||||||
For
|
Against
|
Abstain
|
||||||||||
(2)
|
To
approve the increase in the number of shares of common stock authorized
for issuance under DCT’s 2006 Stock Option Plan from 1,500,000 to
2,500,000.
|
8,236,200
|
224,005
|
-
|
||||||||
(3)
|
To
ratify the appointment of independent registered public accounting
firm,
Clancy and Co., P.L.L.C.
|
11,817,523
|
40,000
|
-
|
Exhibit
Number
|
Description
of Exhibit
|
Method
of Filing
|
||
31.1
|
Certification
Pursuant to Section 302 of the Sarbanes-Oxley Act – David P.
Clark
|
Filed
herewith
|
||
31.2
|
Certification
Pursuant to Section 302 of the Sarbanes-Oxley Act – M. Carolyn Ellis
|
Filed
herewith
|
||
32.1
|
Certifications
Pursuant to Section 906 of the Sarbanes-Oxley Act – David P.
Clark
|
Filed
herewith
|
||
32.2
|
Certifications
Pursuant to Section 906 of the Sarbanes-Oxley Act – M. Carolyn
Ellis
|
Filed
herewith
|
Document
Capture Technologies, Inc.
|
Date:
November 14, 2008
|
/s/ David P. Clark |
David
P. Clark, Chief Executive Officer
|
Date:
November 14, 2008
|
/s/ M. Carolyn Ellis |
M.
Carolyn Ellis, Chief Financial
Officer
|